about
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)Particle transport and deposition: basic physics of particle kineticsNational Athletic Trainers' Association position statement: management of asthma in athletes.Aerosol therapy for obstructive lung diseases: device selection and practice management issues.Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.Randomised controlled trial of the efficacy of a metered dose inhaler with bottle spacer for bronchodilator treatment in acute lower airway obstructionLocal oropharyngeal side effects of inhaled corticosteroids in patients with asthma.The rejuvenated pressurised metered dose inhaler.Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer.The challenge of delivering therapeutic aerosols to asthma patientsElectrostatics of pharmaceutical inhalation aerosols.Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.Electrostatics in pharmaceutical aerosols for inhalation.Formulation considerations for dry powder inhalers.Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.In vitro/in vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients.Evaluation of Proper Usage of Glucocorticosteroid Inhalers and Their Adverse Effects in Asthmatic PatientsSpirometry with bronchodilator test: effect that the use of large-volume spacers with antistatic treatment has on test response.Salmeterol/fluticasone through breath-actuated inhaler versus pMDI: a randomized, double-blind, 12 weeks study.Spacer devices for inhaled therapy: why use them, and how?Optimal Drug-Aerosol Delivery to Predetermined Lung SitesMicroparticle Transport and Deposition in the Human Oral Airway: Toward the Smart SpacerDevelopment of new spacer device geometry: a CFD study (Part I)
P2860
Q26751471-50B4CE60-ED69-4B27-B8E3-FB353D563C79Q28391883-B3024FC2-0D6E-43B1-888E-DCB0C511717AQ28769235-1053E41F-2AD3-4C5E-B0E0-8F627BF65961Q35484494-5FF8185E-195F-46BA-828F-FC8A55EECD47Q35671319-0059D823-611D-4B5F-B80A-BF73D3CF6BD6Q36154407-77127215-CF4C-4460-9139-1312C3AD4534Q36455870-FE643DCF-EEF3-46EB-99A4-A11E8B636331Q36815920-60D8607B-D38A-48F9-ACF5-EF0F064F6139Q36885103-190FC07B-B43E-4878-9EC3-F0E9CF591CC4Q37105708-845D7649-A589-4E8D-95C4-19CF00D51C0CQ37643843-FB2DFDD3-ED88-4E97-A4E3-B85135D39BA1Q37979251-DB2008AF-14DA-4DAE-8BC5-51DB2E4350B3Q38126939-90BE5A73-515A-42BE-B9D1-3E4C63BE0DF9Q38236695-2DB52E25-0FB5-4E5B-9307-7A90B2FC6E95Q39962294-8328A0DF-17A5-4487-8A81-58E2038BC744Q40274049-2665AD50-D564-464C-9B5B-214A9D934B1CQ42428123-A40EB109-CA82-445F-A7D3-CF331B9D3CA4Q50976159-67BC569B-FF58-4604-9927-A8ED2944AAAFQ51602791-979FC2AC-3863-4BC3-B529-B9B4B9CA65C8Q55241851-4EE8D438-C610-4E27-BB7E-71EC52ABA9F2Q57437852-B020EB7C-8F6A-4AE1-8010-847571DA5E68Q58095240-F062E70C-7AEC-4BD0-9B0D-806F5722C874Q58328964-1AB696EB-9505-4F1A-B0BF-B34E9FFCB053
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Spacer devices for metered dose inhalers.
@ast
Spacer devices for metered dose inhalers.
@en
type
label
Spacer devices for metered dose inhalers.
@ast
Spacer devices for metered dose inhalers.
@en
prefLabel
Spacer devices for metered dose inhalers.
@ast
Spacer devices for metered dose inhalers.
@en
P1476
Spacer devices for metered dose inhalers.
@en
P2093
Stephen P Newman
P304
P356
10.2165/00003088-200443060-00001
P577
2004-01-01T00:00:00Z
P6179
1012494629